SetPoint’s neuroimmune modulation platform gets FDA breakthrough device status in MS
The breakthrough device status for the investigational platform technology was given by the US regulator based on data…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Mar 24
The breakthrough device status for the investigational platform technology was given by the US regulator based on data…
28 Nov 23
The KDPP model helps to assess the risk of kidney disease progression and initiation of renal replacement therapy…
27 Oct 23
Transforming the Landscape of Neuro-Oncology Diagnostics Through Non-Invasive Blood-Brain Barrier Opening
25 Oct 23
The MDR certificate encompasses all of RF Medical's product portfolios previously compliant with the MDD
19 Oct 23
This is the third Breakthrough Device Designation granted by the FDA to SeaStar Medical for the SCD device,…
02 Oct 23
The FDA has granted the breakthrough status to SCD for use with patients in the hospital intensive care…
20 Sep 23
Designation expands the availability of Tasso’s patient-centric blood collection solution for decentralized clinical trials, home diagnostic testing, wellness…
11 Sep 23
Klöckner Pentaplast (kp), a global leader in recycled content products and high-barrier protective packaging, has announced it has…
07 Sep 23
This designation accelerates the system's path to market in the United States, where cardiometabolic disorder dominates critical care,…
05 Sep 23
Following the certification, Medimaps Group can continue offering certified TBS iNsight (Osteo) software at the highest standard to…